105 related articles for article (PubMed ID: 22333640)
1. [A case of breast cancer with chronic renal failure successfully treated with TC therapy as adjuvant chemotherapy].
Oshiro C; Arai T; Kamigaki S; Matsuura M
Gan To Kagaku Ryoho; 2012 Feb; 39(2):265-7. PubMed ID: 22333640
[TBL] [Abstract][Full Text] [Related]
2. [Feasibility of adjuvant docetaxel plus cyclophosphamide therapy for breast cancer].
Naito K; Oura S; Yoshimasu T; Nakamura R; Hirai Y; Kiyoi M; Miyasaka M; Okamura Y
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1913-6. PubMed ID: 20948255
[TBL] [Abstract][Full Text] [Related]
3. [Safety and tolerance of docetaxel (especially 75 mg/m2) with cyclophosphamide (TC therapy) as adjuvant chemotherapy for Japanese patients with operable breast cancer].
Watanabe K; Taguchi K; Yamamoto M; Jotoku H; Tamura M
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1265-9. PubMed ID: 20647707
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
[TBL] [Abstract][Full Text] [Related]
5. [A case of acute appendicitis which occurred during chemotherapy for breast cancer].
Oshida S; Hayashi K; Habiro T; Hatate K; Sengoku N
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2417-9. PubMed ID: 24394131
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
[TBL] [Abstract][Full Text] [Related]
7. [Breast carcinoma and bone chondrosarcoma: a new syndrome?].
Guedin P; Chasle J; Blanc-Fournier C; Lacroix J
J Radiol; 2006 Nov; 87(11 Pt 1):1700-4. PubMed ID: 17095966
[TBL] [Abstract][Full Text] [Related]
8. [A case of possible retroperitoneal metastasis of breast cancer successfully treated with oral S-1 and cyclophosphamide therapy after TC therapy].
Yoneyama K; Takeshita T; Suzuki H; Morise M; Suzuki T; Kishi S; Tsutsui A; Matsumoto A
Gan To Kagaku Ryoho; 2011 Mar; 38(3):435-7. PubMed ID: 21403449
[TBL] [Abstract][Full Text] [Related]
9. [Docetaxel plus carboplatin versus EC-T as adjuvant chemotherapy for triple-negative breast cancer: safety data from a phase III randomized open-label trial].
Yuan P; Xu BH; Wang JY; Ma F; Li Q; Zhang P; Fan Y; Li Q; Wang WM
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):465-8. PubMed ID: 22967451
[TBL] [Abstract][Full Text] [Related]
10. Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy.
Yagata H; Kajiura Y; Yamauchi H
Breast Cancer; 2011 Jul; 18(3):165-73. PubMed ID: 21290263
[TBL] [Abstract][Full Text] [Related]
11. Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.
Jones SE; Savin MA; Holmes FA; O'Shaughnessy JA; Blum JL; Vukelja S; McIntyre KJ; Pippen JE; Bordelon JH; Kirby R; Sandbach J; Hyman WJ; Khandelwal P; Negron AG; Richards DA; Anthony SP; Mennel RG; Boehm KA; Meyer WG; Asmar L
J Clin Oncol; 2006 Dec; 24(34):5381-7. PubMed ID: 17135639
[TBL] [Abstract][Full Text] [Related]
12. [Safety and tolerability of docetaxel with cyclophosphamide for early breast cancer].
Kawabata H; Iwatani T; Makuuchi R; Miura D; Suzuki N; Nakazawa H
Gan To Kagaku Ryoho; 2010 May; 37(5):835-9. PubMed ID: 20495312
[TBL] [Abstract][Full Text] [Related]
13. [A case of inflammatory breast cancer achieving pathological complete response by primary systemic therapy with CEF (cyclophosphamide, epirubicin, 5-fluorouracil) followed by docetaxel].
Sagara Y; Rai Y; Sagara Y; Tamada S; Tsuchimochi S; Takahama T; Matsuyama Y; Ando M; Ooi Y; Sagara Y
Gan To Kagaku Ryoho; 2007 Jan; 34(1):77-80. PubMed ID: 17220675
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.
Jones SE; Collea R; Paul D; Sedlacek S; Favret AM; Gore I; Lindquist DL; Holmes FA; Allison MAK; Brooks BD; Portillo RM; Vukelja SJ; Steinberg MS; Stokoe C; Crockett MW; Wang Y; Asmar L; Robert NJ; O'Shaughnessy J
Lancet Oncol; 2013 Oct; 14(11):1121-1128. PubMed ID: 24007746
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.
von Minckwitz G; Kümmel S; Vogel P; Hanusch C; Eidtmann H; Hilfrich J; Gerber B; Huober J; Costa SD; Jackisch C; Loibl S; Mehta K; Kaufmann M;
J Natl Cancer Inst; 2008 Apr; 100(8):542-51. PubMed ID: 18398097
[TBL] [Abstract][Full Text] [Related]
16. [Primary systemic therapy in breast cancer patients (2007-2010)].
Zapf I; Tizedes G; Pavlovics G; Kovács G; Kálmán E; Szalai G; Kövér E; Farkas R; Horváth OP
Magy Seb; 2011 Oct; 64(5):223-8. PubMed ID: 21997525
[TBL] [Abstract][Full Text] [Related]
17. [The safety of docetaxel with cyclophosphamide (TC) therapy as adjuvant chemotherapy for Japanese women with operable breast cancer].
Tashiro H; Sagawa T; Okada K; Kurokawa T; Soga H; Watanabe R; Yasuoka Y; Honda K; Watanabe Y; Gangi J; Akehi S; Masuda J; Nomoto M;
Gan To Kagaku Ryoho; 2007 Mar; 34(3):393-6. PubMed ID: 17353630
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvant chemotherapy in breast cancer.
Livi L; Saieva C; Borghesi S; De Luca Cardillo C; Scotti V; Mangoni M; Greto D; Cataliotti L; Paiar F; Bianchi S; Biti GP
J Chemother; 2009 Nov; 21(5):558-65. PubMed ID: 19933048
[TBL] [Abstract][Full Text] [Related]
19. [A case of primary breast cancer who responded remarkably to the neoadjuvant chemotherapy with the combination of docetaxel and cyclophosphamide].
Yoshibayashi H; Ishiguro H; Takada M; Takeuchi M; Yamashiro H; Ueno T; Kato H; Yoshikawa K; Kanao S; Yamauchi C; Mikami Y; Toi M
Gan To Kagaku Ryoho; 2008 Jun; 35(6):987-90. PubMed ID: 18633230
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of neoadjuvant docetaxel/ vinorelbine followed by surgery and adjuvant doxorubicin/cyclophosphamide in women with stage II/III breast cancer.
Limentani SA; Brufsky AM; Erban JK; Jahanzeb M; Lewis D
Clin Breast Cancer; 2006 Feb; 6(6):511-7. PubMed ID: 16595034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
